New Malaria Test, illumigene® Malaria, Sets a New Gold Standard for Diagnosis

CINCINNATI, Jan. 26 (Korea Bizwire) — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has received the CE Mark for illumigene® Malaria, a novel, highly accurate  test developed by Meridian with the technical assistance of the Centers for Disease Control and Prevention (CDC) and Cheikh Anta Diop University of Dakar, Senegal. The test is up to 80,000 [...]